acquired
Stage
About
Xoma is a biotech royalty aggregator that acquires economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical drug candidates, providing non-dilutive funding to biotech companies.
Explore Xoma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.